SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Shares of Illumina Inc. have fallen nearly 10 percent this week after the gene-sequencing company announced second-quarter revenue missed analysts’ expectations on Tuesday.
Forge Therapeutics Inc., a biotechnology startup in San Diego, announced Tuesday that it has entered into a pilot study with Janssen Research & Development LLC.
Dauntless Pharmaceuticals Inc., a new biopharmaceutical company focused on the development of specialty drugs, announced Tuesday the closing of a $12 million Series A financing.
Sorrento Therapeutics Inc., a late-stage clinical oncology company developing new treatments for cancer and its associated pain, announced that George Uy, executive vice president and chief commercial officer, will leave the company at the end of July to join a startup as its chief executive officer.
San Diego-based Trovagene Inc., a molecular diagnostics company, announced July 17 an offering of 4 million shares of its common stock, which is expected to bring in gross proceeds of around $35 million.
MyDx Inc., creator of a handheld chemical analyzer for consumers, has appointed Tom Gruber as the new chief executive officer effective July 10, 2015.
UC San Diego Health System is losing its well-respected chief executive officer, Paul Viviano, but hospital officials say the loss won’t delay its building boom.
BIOTECH: Talent Likely to Start New Ventures
In one of the largest sales of a San Diego biotech to date, New Jersey-based drug maker Celgene has agreed to purchase Receptos Inc. for $7.2 billion.
IriSys LLC, a San Diego-based pharmaceutical contract development and manufacturing organization, announced Wednesday that it was awarded a five-year contract worth up to $3 million by the National Cancer Institute (NCI).
AnaptysBio Inc., a company developing therapeutic antibodies for inflammation and immuno-oncology, announced Wednesday that it has raised $40 million in an oversubscribed Series D round.
Receptos Inc., one of San Diego’s most promising biotech companies and a favorite or TheStreet's Jim Cramer, will be bought by New Jersey-based pharma giant Celgene Corp. for $7.2 billion.
San Diego-based aTyr Pharma Inc., a public biotherapeutics company developing therapeutics to address severe rare diseases, announced Monday the resignation of President and Chief Operating Officer Frederic Chereau, effective immediately.
NuVasive Inc., a public medical device company in San Diego, announced new executive appointments Monday following the appointment of Greg Lucier to chief executive earlier this year.
Carlsbad health tech firm RF Surgical Systems Inc. will be acquired by Dublin-based Medtronic for roughly $235 million, according to a recent press release.
A local biopharmaceutical company founded by biotech veterans Cam Garner and Ted Schroeder has raised $4.2 million in debt financing, according to a recent filing with the Securities and Exchange Commission.